SG11202107094XA - Process for producing easy-to-take tablets comprising dry extract from ginkgo biloba leaves - Google Patents

Process for producing easy-to-take tablets comprising dry extract from ginkgo biloba leaves

Info

Publication number
SG11202107094XA
SG11202107094XA SG11202107094XA SG11202107094XA SG11202107094XA SG 11202107094X A SG11202107094X A SG 11202107094XA SG 11202107094X A SG11202107094X A SG 11202107094XA SG 11202107094X A SG11202107094X A SG 11202107094XA SG 11202107094X A SG11202107094X A SG 11202107094XA
Authority
SG
Singapore
Prior art keywords
dry extract
ginkgo biloba
biloba leaves
take tablets
producing easy
Prior art date
Application number
SG11202107094XA
Other languages
English (en)
Inventor
Joachim Herrmann
Andreas Rothe
Original Assignee
Dr Willmar Schwabe Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe Gmbh & Co Kg filed Critical Dr Willmar Schwabe Gmbh & Co Kg
Publication of SG11202107094XA publication Critical patent/SG11202107094XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202107094XA 2019-01-15 2020-01-08 Process for producing easy-to-take tablets comprising dry extract from ginkgo biloba leaves SG11202107094XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19151878.6A EP3682870B1 (fr) 2019-01-15 2019-01-15 Procédé de fabrication de comprimes faciles à prendre comprenant un extrait sec des feuilles de ginkgo biloba
PCT/EP2020/050306 WO2020148125A1 (fr) 2019-01-15 2020-01-08 Procédé de fabrication de comprimés à ingestion facile contenant un extrait sec de feuilles de ginkgo biloba

Publications (1)

Publication Number Publication Date
SG11202107094XA true SG11202107094XA (en) 2021-07-29

Family

ID=65033398

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107094XA SG11202107094XA (en) 2019-01-15 2020-01-08 Process for producing easy-to-take tablets comprising dry extract from ginkgo biloba leaves

Country Status (22)

Country Link
US (1) US20220080006A1 (fr)
EP (2) EP3682870B1 (fr)
JP (1) JP7382409B2 (fr)
KR (1) KR20210114974A (fr)
CN (1) CN113365612B (fr)
AU (1) AU2020208564A1 (fr)
CA (1) CA3122196A1 (fr)
CL (1) CL2021001668A1 (fr)
CO (1) CO2021010578A2 (fr)
EC (1) ECSP21059253A (fr)
ES (1) ES2958082T3 (fr)
HR (1) HRP20231170T1 (fr)
HU (1) HUE063900T2 (fr)
IL (1) IL284825A (fr)
MA (1) MA53570B1 (fr)
MX (1) MX2021008522A (fr)
PL (1) PL3682870T3 (fr)
PT (1) PT3682870T (fr)
RS (1) RS64615B1 (fr)
SG (1) SG11202107094XA (fr)
TN (1) TN2021000116A1 (fr)
WO (1) WO2020148125A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023246722A1 (fr) * 2022-06-20 2023-12-28 Aptorum Therapeutics Limited Formulation de comprimé de dioscorea polystachya

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1623593A (zh) * 2003-12-05 2005-06-08 北京博尔达生物技术开发有限公司 银杏叶提取物固体速溶制剂及制备方法
CN1237981C (zh) * 2003-12-31 2006-01-25 北京科信必成医药科技发展有限公司 银杏叶口腔崩解片及其制备方法
CN1273116C (zh) * 2004-06-22 2006-09-06 张晴龙 一种银杏叶口腔崩解片及其制备方法
DE102005014272A1 (de) * 2005-03-24 2006-09-28 Rhein Chemie Rheinau Gmbh Mikrogele und Verdickungsmittel enthaltende Zusammensetzungen
CN1939355A (zh) 2005-09-30 2007-04-04 江西本草天工科技有限责任公司 银杏叶分散片
EP2001450B1 (fr) * 2006-03-31 2019-01-30 Rubicon Research Private Limited Mixture directement compressible pour la manufacture des comprimés se désagrégeant dans la cavité orale
WO2009038145A1 (fr) 2007-09-19 2009-03-26 Asahi Breweries, Ltd. Procédé de production de granulés contenant une matière d'origine naturelle telle qu'un extrait proposé par la médecine traditionnelle chinoise, un extrait de médicament brut, un extrait de matière naturelle ou un mélange de ceux-ci et procédé de production de comprimés à partir des granulés
EP3446696A1 (fr) * 2007-12-21 2019-02-27 Dr. Willmar Schwabe GmbH & Co. KG Utilisation d'un extrait de feuilles de ginkgo biloba
MX341428B (es) 2011-04-27 2016-08-18 Dr Willmar Schwabe Gmbh & Co Kg Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.
CN103976967A (zh) * 2014-06-04 2014-08-13 湖南科技学院 一种银杏内酯舌下片及其制备方法
DE202014005450U1 (de) 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel

Also Published As

Publication number Publication date
CL2021001668A1 (es) 2021-12-31
EP3682870A1 (fr) 2020-07-22
AU2020208564A1 (en) 2021-06-24
KR20210114974A (ko) 2021-09-24
EP4248955A3 (fr) 2023-11-22
CN113365612A (zh) 2021-09-07
MX2021008522A (es) 2021-11-12
EP4248955A2 (fr) 2023-09-27
ECSP21059253A (es) 2021-09-30
HUE063900T2 (hu) 2024-02-28
PT3682870T (pt) 2023-09-25
MA53570A1 (fr) 2022-06-30
TN2021000116A1 (en) 2023-01-05
ES2958082T3 (es) 2024-02-01
JP7382409B2 (ja) 2023-11-16
US20220080006A1 (en) 2022-03-17
CN113365612B (zh) 2023-11-17
IL284825A (en) 2021-08-31
RS64615B1 (sr) 2023-10-31
EP3682870B1 (fr) 2023-08-30
CO2021010578A2 (es) 2021-08-30
WO2020148125A1 (fr) 2020-07-23
HRP20231170T1 (hr) 2024-01-19
MA53570B1 (fr) 2023-01-31
JP2022518163A (ja) 2022-03-14
PL3682870T3 (pl) 2023-12-11
CA3122196A1 (fr) 2020-07-23

Similar Documents

Publication Publication Date Title
ZA202103223B (en) Process for the preparation of (s)-nicotin from myosmine
PL3315610T3 (pl) Sposób wytwarzania fukozylowanych oligosacharydów
RS60029B1 (sr) Novi derivati piperidinila, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
WO2015117793A8 (fr) Procédé amélioré pour la production d'extraits de gingko
EP3395839A4 (fr) Procédé de production de solide sec de nanofibres de cellulose
IL265239A (en) A process for the production of a solid pharmaceutical preparation
HK1259236A1 (zh) 維生素b的雙層片劑及其製備方法
IL265319A (en) Process for preparing 2-exo-(2-methylbenzyloxy)-1-methyl-4-isopropyl-7-oxabicyclo[2.2.1]heptane
ZA201900109B (en) Method for manufacturing intermediate product for conversion into microfibrillated cellulose
IL288958A (en) Exosomes for the treatment of diseases
IL259165A (en) Process for preparing functionalized 1,2,4,5-tetrazine compounds
GB201813186D0 (en) Solid dosage from production
HUE050847T2 (hu) A bauxit kezelési folyamata, beleértve a bauxitmaradvány kezelését szilárd termék elõállítása érdekében
SG11202107094XA (en) Process for producing easy-to-take tablets comprising dry extract from ginkgo biloba leaves
ZA201907077B (en) Method for the procedurally economical removal/fractionation of constituents of vegetal starting material, and the production and use of same
IL215546A0 (en) Process for removing pesticides from ginkgo biloba extracts, and extracts obtainable by said process
WO2016063289A3 (fr) Compositions de comprimé pharmaceutique comprenant de la rifaximine
PL3322487T3 (pl) Ekstrakt z kory magnolii jako hydrofobowy ligand do preferencyjnego usuwania bakterii Gram ujemnych z jamy ustnej
EP3283091A4 (fr) Procédé d'extraction de baies ou fruits à l'aide de composé de magnésium alcalin pour produits pharmaceutiques, végétaux, nutritionnels ou cosmétiques
RO133160B1 (ro) Presă rotativă pentru extracţia uleiului din seminţe oleaginoase
GB201918327D0 (en) Extraction process
SI3409435T1 (sl) Stiskalna naprava za izdelavo lesnih povezkov iz kosov lesa
HK1250140A1 (zh) 製備冷凍乾燥的含有絲裂黴素c的藥物組合物的方法
IL268358B (en) Process for preparing methyl-4-[((4,5-dihydro-3-methoxy-4-methyl-5-oxo-h1- 1,2,4-triazol-1-yl)carbonyl)sulfamoyl]-5-methylthiophene- 3-carboxylate
HK1226255A1 (zh) 一種基於植物藤芯的電子煙煙彈及其製備方法